INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 70 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $844,000 | +15.0% | 49,421 | -8.0% | 0.00% | 0.0% |
| Q4 2018 | $734,000 | -76.9% | 53,747 | -51.6% | 0.00% | 0.0% |
| Q3 2018 | $3,180,000 | +90.1% | 111,134 | +81.8% | 0.00% | 0.0% |
| Q2 2018 | $1,673,000 | +113.7% | 61,133 | +64.6% | 0.00% | 0.0% |
| Q1 2018 | $783,000 | +0.8% | 37,147 | -8.1% | 0.00% | 0.0% |
| Q4 2017 | $777,000 | -18.5% | 40,415 | +5.4% | 0.00% | 0.0% |
| Q3 2017 | $953,000 | -14.1% | 38,339 | -44.7% | 0.00% | 0.0% |
| Q2 2017 | $1,110,000 | +302.2% | 69,349 | +253.9% | 0.00% | – |
| Q1 2017 | $276,000 | -17.1% | 19,595 | -22.9% | 0.00% | – |
| Q4 2016 | $333,000 | -5.9% | 25,420 | +22.1% | 0.00% | – |
| Q3 2016 | $354,000 | -17.7% | 20,814 | +3.4% | 0.00% | – |
| Q2 2016 | $430,000 | – | 20,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |